RecruitingNCT05986461
Spatially Transcriptomics Reveals Molecular Signatures in CRPS
Spatially Resolved Transcriptomics Reveals Phenotype-specific Molecular Signatures in Complex Regional Pain Syndrome
Sponsor
Seoul National University
Enrollment
10 participants
Start Date
Jul 18, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This observational study aims to understand phenotype-specific molecular signatures in patients with complex regional pain syndrome (CRPS).
Eligibility
Min Age: 19 YearsMax Age: 80 Years
Inclusion Criteria4
- Meets the Budapest diagnostic criteria
- Consents to participation in this study
- Aged between 19 and 80 years old
- Symptoms and/or signs of sensory, vasomotor, and sudomotor changes
Exclusion Criteria2
- Who do not agree to participate in this study
- Who has contraindications for skin punch biopsy (e.g. thrombocytopenia, taking anticoagulant drugs)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05986461
Related Trials
TMS for Complex Regional Pain Syndrome
NCT031374721 location
Dance-therapy and Chronic Pain
NCT056899441 location
Supraspinal Processing of Sensory Aspects of Pain
NCT058144971 location
Prednisone for CRPS in Distal Radius Fracture
NCT064534471 location
Pulsed Electromagnetic Fields (PEMFS) in Complex Regional Pain Syndrome Type i (CRPS-I) of the Foot (PeCFoA)
NCT059226181 location